Ambrosia Biosciences Inc. logo

Ambrosia Biosciences Inc.

Small molecule therapies for obesity and metabolic disorders, delivered orally

38 employees · est. 2024 · Boulder, United States

VS
Bostal Drug Delivery logo

Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals since 2013.

est. 2013

Bostal Drug Delivery is the older company (2024 vs 2013).

Side-by-Side Comparison

Ambrosia Biosciences Inc. Bostal Drug Delivery
Founded
2024 2013 older
Headquarters
Boulder, United States Not tracked yet
Employees
38 Not tracked yet
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series B
Total Funding
$125.00M Not tracked yet
Funding Rounds
3 2
Services
Development of small molecule-based therapies, Drug discovery using structure-based approaches, Rapid iteration from initial discovery to IND filings, Discovery of orally delivered therapies for obesity Not tracked yet
Target Customers
Biotechnology investors, Pharmaceutical industry partners, Patients with obesity and metabolic disorders, Scientific community focusing on metabolic and cardiometabolic conditions Not tracked yet
Taxonomy
Small Molecule Therapies, Obesity Treatment, Metabolic Disorders, Drug Discovery, Orally Delivered Drugs, GLP-1, Incretin Hormones, Class B GPCRs, Therapeutics Development, Pharmaceutical Innovation, Novel Drug Compounds Drug Delivery, Pharmaceuticals, Drug Development, Pharmaceutical Technology, Innovation, Generic Drugs, Technical Development, Advanced Drug Delivery, Drug Preparation, Pharmaceutical Manufacturing
Website
ambrosiabiosciences.com bostaldrug.com
Ambrosia Biosciences Inc. logo

About Ambrosia Biosciences Inc.

Ambrosia Biosciences Inc., founded in 2024, is positioned at the forefront of tackling global health challenges in Biotechnology and Pharmaceutical industries. The company is pioneering the development of orally delivered, small molecule-based therapies to address pressing issues such as obesity and...

Bostal Drug Delivery logo

About Bostal Drug Delivery

Bostal Drug Delivery is a biotechnology and pharmaceutical startup that focuses on developing advanced drug preparation products tailored for innovative drug delivery systems. Established in 2013 and based in Guangzhou, Guangdong, the company specializes in creating technology platforms to facilitat...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Ambrosia Biosciences Inc. and Bostal Drug Delivery — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Ambrosia Biosciences I... and Bostal Drug Delivery — by email.

Frequently Asked Questions

Ambrosia Biosciences Inc. — Small molecule therapies for obesity and metabolic disorders, delivered orally. Bostal Drug Delivery — Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals since 2013.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ambrosia Biosciences Inc. has raised $125.00M while Bostal Drug Delivery has raised undisclosed funding.
Ambrosia Biosciences Inc. and Bostal Drug Delivery operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ambrosia Biosciences Inc. with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy